FHI 360 Commends Updated Guidance on Contraception for Women at High Risk of HIV
August 29, 2019
August 29, 2019
DURHAM, North Carolina, Aug. 29 -- FHI 360 issued the following news release:
FHI 360 welcomes the World Health Organization's updated guidance on contraceptive use by women at high risk of acquiring HIV infection and applauds the thoughtful, thorough review process that led to these new recommendations.
Released today, the guidance recommends no restrictions on the use of any reversible contraceptive method -- including progestogen-only injectables and implants and all . . .
FHI 360 welcomes the World Health Organization's updated guidance on contraceptive use by women at high risk of acquiring HIV infection and applauds the thoughtful, thorough review process that led to these new recommendations.
Released today, the guidance recommends no restrictions on the use of any reversible contraceptive method -- including progestogen-only injectables and implants and all . . .